ArticleBioinformatics (Oxford, England)2026
scDAU: a disentangled representation learning method for cross-modal translation in single-cell multi-omics data.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
motivationCross-modal translation enables reconstruction of missing modalities in single-cell multi-omics data, supporting integrative analyses of cellular heterogeneity and regulatory relationships. However, existing methods often struggle to disentangle shared biological signals from modality-specific variation and to generalize across datasets.
resultsWe present scDAU, a deep learning framework that combines conditional diffusion-based feature regularization with multi-scale cross-modal translation networks. scDAU employs a feature decoupling strategy to separate shared semantic representations from modality-specific components, followed by U-Net-based architectures for accurate bidirectional translation between modalities. Across multiple benchmark datasets, scDAU outperforms existing methods in both within-dataset and cross-dataset settings, as well as in predicting modalities for previously unseen cell types. The framework further generalizes to transcriptome-proteome translation, demonstrating flexibility across diverse multi-omics contexts. Application to a human glioblastoma dataset showed that scDAU preserves cell-type-specific gene expression and chromatin accessibility patterns, supporting downstream analyses such as marker identification and functional enrichment. Overall, scDAU provides a robust and extensible approach for cross-modal translation. AVAILABILITY: The source code of scDAU is available at https://github.com/zhyu-lab/scdau and https://doi.org/10.5281/zenodo.19303337.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.